Greg Keenan - 01 Aug 2025 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Medical Officer
Signature: /s/ Greg Keenan, M.D.
Issuer symbol: AUPH
Transactions as of: 01 Aug 2025
Net transactions value: -$210,000
Form type: 4
Filing time: 05 Aug 2025, 16:07:28 UTC
Previous filing: 07 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Keenan Greg	Chief Medical Officer	#140, 14315 - 118 AVENUE, EDMONTON, ALBERTA, CANADA	/s/ Greg Keenan, M.D.	05 Aug 2025	0002044006

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Sale	$210,000	-20,000	-13%	$10.50	133,484	01 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.